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Summary 
To study the role of thymic education on the development of the human T cell repertoire, SCID- 
hu mice were constructed with fetal liver and fetal thymus obtained from the same or two different 
donors. These animals were studied between 7 and 12 mo after transplantation, at which times 
all  thymocytes and peripheral T  cells were derived from stem cells of the fetal liver  graft. 
Immunohistology of the thymus grafts demonstrated that thymic epithelial cells were of fetal 
thymus donor (FTD) origin. Dendritic cells and macrophages of fetal liver donor (FLD) origin 
were abundantly present in the medullary and cortico-medullary areas. Thymocytes of SCID-hu 
mice transplanted with liver and thymus of two different donors (FLDA/FTDB animals) were 
nonresponsive to Epstein-Barr virus-transformed B cell lines (B-LCL) established from both the 
FLDA and FTDB,  but proliferated vigorously when stimulated with  third-party allogeneic 
B-LCL.  Mixing experiments showed that  the nonresponsiveness to  FTDB  was  not  due to 
suppression.  Limiting  dilution  analysis  revealed  that  T  cells  reacting  with  the  human 
histocompatibility leukocyte antigens (HLA) of the FLD were undetectable in the CD8 + T cell 
population and barely measurable in the CD4 + subset.  On the other hand, CD4 + and CD8 + 
T cells reactive to the HLA antigens of the FTD were readily detectable. These results indicate 
that FLD-reactive  cells were clonally deleted, whereas FTD-reactive cells were not. However, 
the frequencies of FTD-reactive T  cells were consistently twofold lower than those of T  cells 
specific for any third-party B-LCL. In addition, the cytotoxic activity and interleukin 2 production 
by FTD-specific T  cells were lower compared with that of third-party-reactive T  cell clones, 
suggesting that FTD-specific cells are anergic. These data demonstrate that T cells become tolerant 
to autologous and allogeneic HLA antigens expressed in the thymus via two different mechanisms: 
hematopoietic cells present in the thymus induce tolerance to "self"-antigens by clonal deletion, 
whereas thymic epithelial cells induce tolerance by clonal anergy and possibly deletion of high 
affinity clones. 
D 
uring the last several years, our knowledge of the role 
of the thymus in the induction of self-tolerance has dra- 
matically expanded primarily due to the availability of trans- 
genic animal models (1) and the discovery of endogenous su- 
perantigens (2) in laboratory mice. Immature thymocytes that 
express TCR recognizing self-peptide-MHC complexes present 
in the thymus can be physically eliminated by clonal deletion 
(3-6). Although clonal deletion is believed to be an impor- 
tant mechanism in the acquisition of self-tolerance  in the 
normal thymus, it was demonstrated that thymocytes with 
self-reactive TCR are not always deleted, but rather func- 
tionally inactivated (7-9). This phenomenon of clonai anergy 
is not yet well understood. In addition, little is known of 
the factors determining the induction of clonal deletion or 
clonal anergy. The affinity of the MHC-peptide-TCR inter- 
action and/or the nature of the cell that presents the antigen 
have been implicated (10, 11). Hematopoietic cells, in partic- 
ular B cells and dendritic cells (DC), 1 are very potent in- 
ducers of clonal deletion (12-15). In contrast, thymic epithe- 
lium is incapable or less effective in dictating clonal deletion 
(7, 10, 16), but equally effective in inducing tolerance (17-19). 
Due to the lack of suitable models to study thymic educa- 
tion in humans, it is unclear to what degree the data ob- 
1 Abbreviations used in this~per: DC, dendritic cell; FLD, fetal liver donor; 
FTD, fetal thymus donor; Mq~, macrophage. 
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ular, it remains to be determined whether self-tolerance  is 
achieved in the human thymus by clonal deletion of autoreac- 
tive cells. In addition, little is known about the nature of 
the cells responsible for the induction of tolerance.  Informa- 
tion relevant to these questions has been obtained by studying 
the peripheral T cell repertoire in SCID patients reconstituted 
with allogenic fetal liver stem cells (20,  21). In these sub- 
jects, tolerance can be achieved in vivo to both the donor 
and host HLA antigens. This is the case even when the trans- 
plant results in a split peripheral chimerism where only the 
T lymphocytes come from the donor and all other hemopoietic 
lineages are of host origin. We demonstrated that this toler- 
ance is not due to clonal deletion of donor T  cells recog- 
nizing the host HLA antigens since host-reactive T cell clones 
were isolated in high frequencies  in vitro (22).  In contrast, 
no donor-reactive T cells could be detected, suggesting that 
these cells were clonally deleted (21). These studies prompted 
us to hypothesize that after allogenic stem cell transplanta- 
tion, not only T  cells but also macrophages (M~), B cells, 
and DC differentiate from the donor stem cells in the host 
"chimeric" thymus (23,  24),  whereas the thymic epithelial 
cells are exclusively of host origin. As shown in experimental 
models (1-17), the thymic epithelial cells would then be able 
to induce positive selection but not clonal deletion of host- 
reactive T cells, whereas the hematopoietic elements would 
delete the donor-reactive T  cells. 
To test this hypothesis and to investigate the mechanisms 
that regulate tolerance induction in the human (chimeric) 
thymus, we took advantage of the SCID-hu model described 
by McCune et al. (25).  Human fetal liver and human fetal 
thymus tissue of the same or two different donors were coim- 
planted under the kidney capsule of SCID mice. In these trans- 
planted mice, stem cells from the fetal liver migrate to the 
fetal thymus and differentiate into single-positive T lympho- 
cytes (26).  These cells finally migrate to the periphery as a 
mature, functionally  competent, and polyclonal T cell popu- 
lation (27,  28).  The reactivity of these T  cells towards the 
HLA antigens of the fetal liver donor (FLD) and the fetal 
thymus donor (FTD) was studied. The HLA phenotype of 
the various cell populations present in the thymus, determined 
in parallel,  showed that FLD gave rise to the hematopoietic 
elements, whereas the thymic epithelium derived from the 
FTD. Results demonstrate that tolerance towards both the 
FLD and the FTD is achieved. T cells specific for the "self"- 
HLA antigens expressed  by the FLD are clonally deleted, 
whereas a significant proportion of FTD-reacting T cells is 
still present, but these cells are anergic. 
Materials and Methods 
Mice.  C.B-17  scid/scid mice were transplanted with small pieces 
of fresh human fetal liver and thymus under the kidney capsule 
as described (26). Each mouse was transplanted with thymus and 
liver from the same or from two different  fetal donors. Fetal donors 
between 15 and 21 wk gestational age were used. No attempts 
were made to deplete the thymus grafts of  endogenous thymocytes. 
However, in most animals endogenous thymocytes are completely 
replaced by fetal liver derived cells by 3 mo after transplantation 
(26). SCID-hu mice, with thymocytes exclusively  of FLD origin, 
were studied between 7 and 12 mo after transplantation. The fol- 
lowing sets of SCID-hu mice were used: 2868, constructed with 
liver and thymus of fetal donor L064; 2869, constructed with ma- 
terial from FLD L064 and FTD L065; 1310, constructed with 
material from FLD K395 and FTD SV031; IM93, constructed 
with material from FLD Fl115 and FTD Fl116; C222, construc- 
ted with material  from FLD F215 and FTD F214; C223, constructed 
with liver  and thymus of  fetal  donor F215. In all cases a mAb against 
an HLA class I and HLA class II allotypic determinant was avail- 
able to discriminate between FTD and FLD. 
Cell Lines.  B-LCL  autologous to the transplanted  material  were 
generated by infection of pretransplant fetal liver or fetal thymus 
cells with EBV obtained from the marmoset cell line B95.8. T cell 
lines were derived from fetal liver or thymus by PHA stimulation 
in the presence of Ib2 (28). Each cell line was typed for HLA an- 
tigens by conventional serological techniques. The B-LCL used as 
targets for cytotoxicity tests were never kept in  culture  for a 
prolonged time, since this dramatically  increased LAK sensitivity. 
mAbs.  The following purified  mAbs against allotypic  HLA de- 
terminants were used for FACS  |  analysis  (Becton Dickinson & Co., 
Mountain View, CA) and histochemical  staining: MA2.1 (anti-A2), 
BB7.1 (anti-B7), BB7.2 (anti-A2), MB40.2 (HLA-B7), GAP-A3 
(HLA-A3), and SFR3-DR5 (HLA-DRS) (obtained  from the Amer- 
ican Type Culture Collection, Rockville, MD). PD3 (polymorphic 
DR determinant), 7.3.19.1 (DRw52), and IIB3 (polymorphic DQ 
determinant) were kindly provided by Dr. H. Bruning (University 
Hospital, Leiden, The Netherlands). XIII and 3E3 (polymorphic 
DR determinant) and logD6 (DRw53) were kindly provided by 
Dr. R. Bontrop (TNO, Rijswijk, The Netherlands). Leu-2, Leu- 
3, Leu-4, Leu-6, Leu-12, Leu-15, Leu-M3, Leu-M5, and HLE were 
purchased from Becton Dickinson & Co.). 
Fluorescence Analysis.  10  s cells were labeled with mAbs and 
FITC-labeled goat anti-mouse antibody as described  previously  (28). 
For double labeling  experiments, after FITC labeling, the cells were 
washed twice in medium containing 1% normal mouse serum, 
and a PE-conjugated mAb was added. The cells were incubated 
for 30 rain with the appropriate mAb in PBS with 0.1% BSA and 
NaN3 in all staining experiments. 
Immunohistologic Staining of Tissue Sections.  One-third  of the 
SCID-hu thymus-like structures were embedded in OCT medium 
and snap  frozen  in liquid nitrogen. The tissues were stored at - 70~ 
until sectioning. Sections (5/~m) were acetone fixed, washed in 
PBS, and then subsequently  incubated  with an HLA class II-specific 
mAb followed  by biotinylated  horse anti-mouse IgG (Vector  Labora- 
tories, Inc., Burlingame, CA). Alkaline phosphatase (ALP)-con- 
jugated avidin (Caltag Laboratories,  South San Francisco, CA) was 
added and visualized using the substrate naphthol-AS phosphate 
(Sigma Chemical  Co., St. Louis,  MO) with fast blue BB salt (Sigma 
Chemical Co., St. Louis, MO). Endogenous phosphatase activity 
was blocked  by adding levamisole  (0.25 mM) in the reaction. Slides 
were counterstained with hematoxylin and mounted in glycerin- 
gelatin. Immunofluorescence  was used for double staining of sec- 
tions. For double staining with keratin and HLA class II-specific 
mAb, the sections were first stained with an HLA class II-specific 
mAb, then stained  with Texas red-conjugated goat anti-mouse IgG 
(Caltag Laboratories). Next, tissues were stained with rabbit an- 
tikeratin (Dakopatts, Copenhagen, Denmark) and FITC-labeled 
goat  F(ab')2 anti-rabbit  IgG (Caltag Laboratories). For double 
staining with CD1 (Leu-6) or CD11c (Leu-MS) mAb and HLA- 
specific mAbs, tissues were sequentially  incubated with HLA class 
II-specific mAb, biotinytated horse anti-mouse Ig (Vector Labora- 
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tions with 5% normal mouse serum, tissues were stained with ei- 
ther PE-labeled anti-CD1 (Leu-6) or CDllc (Leu-M5). 
Proliferation Assay.  The proliferation of the total thymocyte 
populations was tested in a MLR by stimulating 2 x  10  s thymo- 
cytes with 2  x  104 irradiated B-LCL in round-bottomed micro- 
titer plates. These cultures were incubated for 5 d at 37~  in a 
humidified atmosphere of 5% COz. During the last 16 h, 1/~Ci 
of [3H]thymidine  was added. Subsequently, the cultures were har- 
vested onto fiberglass filters, and [~H]thymidine  incorporation was 
determined by liquid scintillation spectroscopy. 
Limiting Dilution Analysis for Lymphokine-secreting  and Cytotoxic 
T Cells.  Thymocyte suspensions were obtained by squeezing the 
dissected thymic structure through steel mesh with the plunger 
of a tuberculin syringe. After washing and counting the cells, 10 
/~1/106 cells of Leu-3-FITC and Leu-2-PE was added to the cell 
pellet. The cells were placed on ice for 30 min and washed once. 
Single-positive CD4 and CD8 thymocytes were obtained by cell 
sorting  on  a FACStar Plus  |  (Becton Dickinson  &  Co.).  The 
CD4 + or CD8 + cells were then seeded manually at 0 (for back- 
ground determination), 1 (for determination of doning efficiency), 
and 20 cells/well in 96-weU U-shaped microtiter plates in 50/zl 
Yssers medium. A volume of 50/zl of a feeder cell mixture was 
added consisting of l&/ml PBL (irradiated, 4,000 rad), 10S/ml  JY 
B-LCL (irradiated, 5,000 rad), and 0.1 #g PHA/ml. After 1 wk, 
100 ~1 of culture medium was added which contained 20 IU of 
IL-2/mL Hereafter, the procedure differed  for helper and cytotoxic 
precursor frequency determination. 
For determination of cytotoxic precursor frequencies, the CD8 § 
ceils were incubated for an additional 5 d. A volume of 130/zl was 
taken from each well and transferred to V-shaped 96-well plates. 
After washing the cells in the V-shaped 96-well plate, the contents 
of each weU were split and transferred into two U-shaped 96-weU 
plates for the determination of cytotoxic activity. For each target, 
five plates seeded with 20 cells/well and one plate seeded with 0 
cells/well were tested in duplicate. The cytotoxicity was assayed 
as described previously  (29). In brief, 2  x  103 SlCr-labeled  B-LCL 
or 5 x  10  ~  PHA blasts were added to the various plates containing 
the effector cells in a final volume of 0.2 ml of culture medium. 
The plates were centrifuged and subsequently incubated for 4 h 
at 37~  in a humidified atmosphere of 5% CO2. The supema- 
rants were harvested using a harvesting system (Skatron, Sterling, 
VA) and counted in a gamma counter. The percentage specific 
SlCr-release was calculated as described (29). 
To determine  lymphokine-secreting  cells, the cultures (containing 
either CD4 § or CD8 + thymocytes) were incubated for an addi- 
tional 1 wk. The contents of each well were then transferred to 
a V-shaped 96-well plate and washed three times with PBS. Subse- 
quently, the contents of  each well were resuspended in 150 #1, and 
50-#1 aliquots were transferred to the individual wells of three flat- 
bottomed microtiter plates. In this way,  each culture could be tested 
for lymphokine secretion after stimulation with three different 
B-LCL. A total of 10  s irradiated (5,000 rad) B-LCL was added as 
stimulators to each well in a final volume of 200/~1. Five plates 
seeded with 20 cells/well and one plate seeded with 0 cells/well 
for background were usually analyzed  per test. After 20 h of incu- 
bation at 37~  for determination of Ib2 content, or 48 h for de- 
termination of IFN-3, content, 100/zl of supernatant was harvested 
from each well Ib2 activity was assayed  in duplicate on the mouse 
cell line CTLL-2 as described by Gillis et al.  00).  IFN-'r  was 
quantified  in duplicate  with an immunoenzymatic  assay  as described 
previously (31). 
Calculation ofCytotoxic or Hd~r Frequencies.  A culture was con- 
sidered positive when the lower value of the duplicate determina- 
tion was higher than the mean of 96-well background determina- 
tions (0 cells/well plate) plus three times the SD. The cloning 
efficiency  (CE) was determined by visual scoring for growth of 96 
wells seeded with 1 cell/well at the beginning of the experiment. 
CE was usually around 20%. The precursor frequency was calcu- 
lated as follows: 1/frequency =  -In (number of  negative  wells/total 
number of  wells)/[(CE/100) x 20]. Absolute frequencies  meast/red 
against a particular B-LCL  were reproducible  between experiments. 
Nevertheless, measurements  of FLD, FTD, and third-party-specific 
precursor frequencies were always determined in  the  same ex- 
periment. 
Results 
Origin of Mature T  Cells in SCID-hu Mice.  Human liver 
and thymus were obtained from two different fetal donors, 
L064 and L065. A limited HLA phenotype performed on 
B-LCL of both donors with mAbs specific for HLA class 
I allotypic determinants demonstrated that donor L064 was 
HLA-A2-,B7 +, whereas donor L065  was HLA-A2+,B7 - 
(Fig.  1). Two sets of SCID-hu mice were constructed with 
these donors: the 2868 animals, with fetal liver and thymus 
from donor L064; and the 2869 animals, in which fetal liver 
of donor L064 was coimplanted with fetal thymus of donor 
L065. 7 mo after transplantation, the mature human single- 
positive thymocytes and peripheral T cells present in SCID- 
hu 2868.1 or 2869.1 were sorted, cultured with PHA in the 
presence  of II.-2, I1.-6, and IFN-y for 5 d to increase HLA 
expression,  and phenotyped. As shown in Fig. 1, >99% of 
the  CD4 +  and  CD8 +  single-positive  thymocytes  were 
HLA-A2 negative and HLA-B7 positive in both animals, in- 
dicating that virtually all mature human T cells had differen- 
tiated from L064 fetal liver stem cells in the L064 or L065 
human thymuses. Comparable findings were obtained in all 
animals used in this study. 
On'gin of  HLA Class II-positive Cells Present in the SCID-hu 
Thymus.  To investigate which cell types other than T cells 
were present in the SCID-hu thymus at the time of the study 
and to define their origin, sections of  thymus graft were stained 
with mAbs specific for the HLA class II antigens of either 
FTD or FLD. As shown for SCID-hu 1310.2 in Fig. 2 B, 
a mAb specific for an HLA class II polymorphic determinant 
expressed by the FLD intensively stained the medullary and 
corticomedullary area. In contrast, a mAb specific for an FILA 
class II polymorphic determinant expressed by FTD cells pre- 
dominantly stained cortical thymic epithelium, whereas iso- 
lated cells were stained in the medulla (Fig. 2 A). To deter- 
mine the nature of the cells expressing HLA class II, sections 
were double stained with an HLA dass II-specific allotypic 
marker in combination with a mAb specific for either ker- 
atin as an epithelial cell marker (Fig.  2, C and D), or CD1 
as a marker for DC in the medulla (32,  33) (Fig.  2, E  and 
F), or CDllc as a tissue M~ and DC marker (34, 35) (Fig. 
2, G, H, I, and  j). Most of the FTD-derived cells with den- 
dritic morphology in the medulla were keratin positive (Fig. 
2, C and D), which indicates that these cells are HLA class 
II-positive  medullary  thymic  epithelium.  No  medullary 
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Figure 1.  HLA phenotype of fetal donors and SCID-hu single-positive 
thymocytes. Cultured B-I.CL derived  from fetal  donor L064 (A) and L065(B) 
were stained with the HLA-A2-specific mAb MA2.1 (clear histogram) or 
the HLA-B7 specific  mAb MB40.2 (filled histogram). CD4+CD8 -  (C and 
D) and CD8 +  CD4-  (E and F) T  cells were purified by FACS  |  from 
SCID-hu 2868.1 (C and E) and 2869.1 (D and F) thymocytes. Cultured 
cell lines established from these purified populations  were stained with 
MA2.1 and MB40.2 mAbs. The percentage of MA2.1-positive cells was 
0.4% (C); 0.0% (/9); 0.2% (E); and 0.1% (F). The percentage of MB40.2- 
positive cells was 98.8%  (C); 99.9%  (D); 99.7% (E); and 99.8% (F). 
CD1 + cells with dendritic morphology stained with the 
FTD HLA dass II marker (data not shown), whereas virtu- 
ally  all  CD1 +  cells  with  dendritic  morphology  were 
brightly stained with the mAb specific for the HLA class 
II of the FLD (Fig.  2, E  and F), indicating that by 7 mo 
after transplantation, all endogenous DC are replaced by FLD- 
derived DC. In addition, >99% of CD11c § cells were posi- 
tive for the FLD-specific marker (Fig.  2, G, H, I,  and j), 
however,  in  one  animal  of the  2869  series, 5%  of  the 
CD11c + monocyteqike cells of FTD origin were present by 
7 mo after transplantation. Collectively, these data show the 
gradual complete turnover of endogenous medullary and cor- 
ticomedullary HLA class II-positive hematopoietic cells by 
FLD-derived cells after transplantation, with conservation of 
normal histological features. 
Reactivity in  MLR  of FLDa/FTDA  and FLDJFTDB 
SCID-hu Thymocytes.  To study the role of the thymic envi- 
ronment on the development of T cell tolerance, MLR were 
performed. A representative example of the results obtained 
in six experiments performed with thymocytes obtained from 
different SCID-hu mice is shown in Fig.  3.  Unseparated 
thymocytes obtained from 2868.2 (FLD^/FTDA) SCID-hu 
thymus proliferated vigorously when stimulated with any 
third-party B-LCL tested, including L065. In contrast, only 
marginal proliferation was observed in response to the autol- 
ogous B-LCL L064 (Fig. 3 A). Thymocytes of SCID-hu an- 
imal 2869.2 (FLDA/FTDB) likewise responded to the third- 
party B-LCL SV031 and K395 but did not proliferate when 
stimulated with either the FLD L064 or the FTD L065 (Fig. 
3 B). The observed nonresponsiveness to the donor of the 
fetal thymus L065 was not due to altered kinetics since time 
course experiments indicated that thymidine incorporation 
was never significantly above background (data not shown). 
To determine whether suppressive activity could account for 
the nonresponsiveness towards the FTD, we performed a MLR 
in which unirradiated 2869.3  (FLDA/FTDB)  "regulator" 
thymocytes were mixed at various ratios to 2868.3 (FLDA/ 
FTDA) "responder" thymocytes and stimulated with L064 
(Fig. 4 A), L065 (Fig. 4 B), or a third-party B-LCL (Fig. 
4 C). The total cell numbers were kept constant. Responses 
of the mixture were always intermediate to those of the in- 
dividual unmixed thymocytes. Significant proliferation after 
stimulation with the L065 B-LCL occurred even at responder- 
to-regulator ratios as low as 1:3. Collectively, these data show 
that T cells become nonresponsive to the HLA antigens ex- 
pressed by the FTD during development in the thymus and 
that this nonresponsiveness is not due to the presence of in- 
hibitory interactions between cells. 
Frequencies of CD4 § T Cells Specific.for the HLA Antigens 
Expressed by FLD or FTD  To investigate whether the ac- 
quired nonresponsiveness of FLD^/FTDB SCID-hu thymo- 
cytes to the FTD HLA antigens was due to clonal deletion 
or anergy, a sensitive and quantitative limiting dilution assay 
was developed. In this assay, limiting numbers of CD4 single- 
positive thymocytes were stimulated with PHA in the pres- 
ence of irradiated feeder cells and IL-2. The cells were ex- 
panded for 2 wk and were then tested for their ability to 
produce II;2 upon stimulation with the FTD, FLD, or third- 
party-derived B-LCL. After stimulation of individual oligo- 
clonal cultures of 2868.2 (FLD^/FTDA) CD4 + thymocytes 
with the autologous B-LCL (Fig. 5 A), only a few cultures 
secreted I1;2 above background. Significantly more positive 
cultures and higher I1;2 levels were observed after allogeneic 
stimulation with L065 and K395 (Fig. 5, C and E). After 
stimulation with the allogeneic K395 B-LCL (Fig. 5 F), the 
responses  of CD4 + thymocytes from the 2869.2  (FLDA/ 
FTDB) SCID-hu mouse were in the normal range. Interest- 
ingly, although the MLR responses  of 2869.2  thymocytes 
to L064 or L065 were both negative,  clearcut positive I1;2 
responses were observed in this assay against FTD L065 (Fig. 
5 D) but not against FLD L064 (Fig. 5 B). A summary of 
four experiments performed with CD4 + thymocytes from 
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hu chimeric thymus: characterization of 
HLA class II-positive cells in thymus 
of SCID-hu 1310.2 7 mo after trans- 
plantation. The FLD K395 was posi- 
tive for IIB3 and negative for PD3, the 
FTD SV031 was positive for PD3 and 
negative for IIB3. Both mAbs recog- 
nize an HLA class II determinant. (A) 
Immuno-enzymic  staining with PD3. 
A fine reticular staining of the cortex 
contrasts with scantly stained medulla 
(center). The corticomedullary area does 
not show a concentration  of PD3 posi- 
tive cells. (B) Immuno-enzymic staining 
with IIB3. Isolated cells are positive in 
the cortical area. Oval monocyte-like 
cells  and  cells with  dendritic  mor- 
phology at the corticomedullary junc- 
tion and medulla are brightly positive. 
(C and D) Two-color staining with ker- 
atin (C)  and PD3  (D).  High-power 
magnification of a medullary area with 
bright PD3 staining  demonstrates that 
the HLA class II of FTD origin is ex- 
pressed by keratin-positive thymic epi- 
thelial cells. (E and F) Two-color stain- 
ing  with  CD1  (E)  and  IIB3  (F). 
Irregularly shaped CD1 + cells  located 
in the medulla  were considered DC. 
High magnification of the medullary 
area shows CD1 + cells that are posi- 
tive for  IIB3.  (G and /4)  Two-color 
staining with CDllc (G) and IIB3 (/4). 
CD11c + cells  express variable levels of 
HLA class II antigens of the FLD on 
the membrane. A few scattered Mq~ are 
seen in the cortex. (I and.]) Two-color 
staining with CDllc (/) and PD3 (]). 
CD11c +  cells are  seen  at  the  cor- 
ticomedunary and medullary area. None 
of the cells  express  HLA Ag of the FTD. 
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Figure 4.  Proliferation of different ratios of thymocytes of SCID-hu 
2868.3  (FLD^/FTD^),  constructed  with  fetal material  of L064, and 
2869.3 (FLD^/FTDB), constructed with material of FLD L064 and FTD 
L065, in response to stimulation with L064 (A), L065 (B), and JY (C), 
a third-party  B-LCL. 
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Figure 3.  Proliferative responses of 
SCID-hu 2868.2 and 2869.2 thymocytes 
upon stimulation  with B-LCL of FLD 
(L064), FTD (L065), and third-party 
B-I.CL  K395  and  SV031. (A)  The 
proliferative  responses  of thymocytes  ob- 
tained from  SCID-hu animal 2868.2 
(FLD^/FTD^), constructed with fetal 
liver and thymus of donor L064; (B) 
proliferative responses of thymocytes 
from SCID-hu 2869.2 (FLD^/FTDB), 
constructed with material of FLD L064 
and FTD L065. 
however, they never reached the frequencies measured against 
third-party B-LCL. The effect of thymic education on FTD- 
specific T  cells can be quantified by taking the ratio of the 
frequency of T  cells specific for a particular B-LCL  in the 
T  cell compartment of SCID-hu mice 2868 (FLD^/FTD^) 
to  the frequency of the cells  with  the  same  specificity  in 
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Figure 5.  II.-2  production (expressed as ~m of the CTLL-2 cell line) 
by individual  cultures after stimulation with FLD LIRI4 (A and B), FTD 
L065 (C and D), and third-party B-LCL K395 (E and F). A total of 192 
individual cultures of CD4 + thymocytes are shown for each stimulator. 
CD4 +  thymocytes  were  obtained  from  SCID-hu  animal  2868.2 
(FLDA/FTDA), constructed  with fetal liver and thymus of donor L064 
(H, C, and E), and from SCID-hu 2869.2 (FLDA/FTDB), constructed 
with material of FLD L064 and FTD L065 (B, D, and F). 
1038  Tolerance  Induction in SCID-hu Mice Table  1.  Frequency  of IL-2-producing CIM § Thymocytes Specific  for FLD, FTD, and Third-party Alloantigens 
Frequency of T cells specific for: 
Exp.  SCID-hu  FLD  FTD  L064"  K395  L065  SV031 
1  1310.2  K395  SV031  1:31  1:180  ND  1:120 
2  1310.5  K395  SV031  1:41  1:1,000  ND  1:56 
3  2869.1  L064  L065  1:362  1:34  1:72  ND 
2868.1  L064  L064  1:205  1:47  1:32  ND 
4  2869.2  L064  L065  1:808  1:114  1:89  ND 
2868.2  L064  L064  1:405  1:89  1:57  ND 
*  B-LCL. 
SCID-hu  2869 (FLD^/FTDe).  This ratio is  2.3  (Table  1, 
Exp. 3)  and 1.6  (Table  1,  Exp. 4) for L065,  and "~1 (0.72 
and  1.28,  respectively) for the third-party B-LCL K395. 
Frequencies of CD8 + T Cells Specific for the HLA Antigens 
Expressed by FLD or FTD  Since specific cytotoxic activity 
could not be generated in MLR when thymocytes were stimu- 
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Figure 6.  Percentage  of lysis of FLD-derived  B-LCL  K395 (.4), FTD- 
derived B-LCL SV031 (/3), and third-party  target Fl115 (C) by 384 in- 
dividual cultures of CD8 + thymocytes.  The effector  cells were CD8 + 
thymocytes  obtained  from SCID-hu 1310.5 (FLD^/FTDB),  constructed 
with material of FLD K395 and FTD SV031. The percentage  of lysis by 
the FTD-specific  cultures (cultures  which gave significant lysis of SV031 
targets) was significantly  lower than the percentage  of lysis by the FIllS- 
specific cultures (Wilcoxon  rank test: p <0.05). 
lated with allogeneic B-LCL (36), a cytotoxicity assay was 
developed that bypasses the need for helper cells. CD8 single- 
positive thymocytes were isolated and stimulated with PHA 
in the presence of irradiated feeder cells and Ib2 as described 
for CD4 +  cells.  12  d  later,  each culture  was  assayed  for 
specific killing of FLD, FTD, or third-party B-LCL. One 
such experiment is shown in Fig. 6,  and a summary of all 
results expressed as frequencies is shown in Table 2.  High 
frequencies of allospecific  cytotoxic cells with high lytic ac- 
tivity were obtained in such experiments, whereas the fre- 
quencies of cytotoxic cells  specific for FLD HLA antigens 
were near the detection limit. CD8 § cells that specifically 
lysed FTD B-LCL were easily detectable, but the frequencies 
of these cells were on average twofold lower than those of 
allospecific  B-LCL (Table 2).  Comparable results were ob- 
tained when PHA blasts were used as target instead of B-LCL, 
excluding the possibility that EBV-specific lysis restricted by 
the HLA of the FTD was measured in these assays. Further- 
more, it was consistently found in all experiments that the 
average percentage of  lysis observed in individual cultures cyto- 
Table 2.  Frequency  of Cytotoxic CD8 § Thymocytes Specific  for 
FLD, FTD, and Third-party Alloantigens 
Frequency of T  cells specific for: 
SCID-hu*  Target  FLD  FTD  Third party 
1310.2  PHA blast  1:3,010  1:301  1:251 
B-LCL  1:2,730  1:455  1:152 
1310.5  B-LCL  1:1,200  1:150  1:62 
IM93  PHA blast  1:2,520  1:420  1:252 
B-LCL  <1:1,600  1:192  1:73 
* All SCID-hu mice were constructed  with fetal liver and thymus from 
different donors. 1310.2 and 1310.5 were constructed with material 
from FLD K395 and FTD SV031; IM93 was constructed  with material 
from FLD Fl115 and FTD Fl116. 
1039  Vandekerckhove  et al. toxic for the FTD was lower than that measured in individual 
cultures cytotoxic for third-party targets (Fig. 6). To exclude 
that these lower frequencies of FTD-specific CD8 + cells, as 
determined by specific cytotoxicity, were due to the presence 
of noncytotoxic FTD-specific CD8 * cells, large numbers of 
fresh CD8 + cells were stimulated with PHA in the presence 
of feeders and I1:2 as described above and subsequently tested 
for specific IL-2 or IFN-3, production after stimulation with 
the FTD or third-party B-LCL.  CD8 § T  cells specific for 
third party or FTD were reproducibly detected only in the 
Ib2 assay and are shown in Table 3. The frequencies of 11:2- 
producing CD8 + T cells were indeed higher than those ob- 
served in the cytotoxic assay. This was probably due to the 
different sensitivity of the two tests. However, CD8 + T cells 
specific for FTD were again detected at about twofold lower 
frequencies than third-party-reactive T  cells. 
Discussion 
To better understand the events that regulate T cell recon- 
stitution and induction of tolerance after allogeneic stem cell 
transplantation in humans, we transplanted SCID mice with 
human fetal liver and thymus obtained from two different 
HLA-mismatched donors. In these SCID-hu mice, pluripo- 
tent stem cells of fetal liver origin migrate to the human al- 
logeneic thymus and differentiate to mature single-positive 
thymocytes that give rise to a functional polyclonal T  cell 
repertoire in the periphery (26-28). 
By transplanting genetically identical human stem cells in 
different thymic environments, we showed that the alloreac- 
tire T cell repertoire is profoundly altered by the HLA an- 
tigens expressed in the thymus. Stem cells that differentiated 
in an allogeneic thymus gave rise to T cells that did not re- 
spond to the HLA antigens of the FTD as well as of the 
FLD. This tolerance was specific for the alloantigens expressed 
in the thymus and was not genetically determined but ac- 
quired during differentiation in the thymus. Similar results 
have been obtained in murine models of transplantation.  Toler- 
Table  3.  Frequency of lL-2Troducing CD8 + Thymocytes 
Specific for FLD,  FTD, and Third-Party AIIoantigens 
Frequency of T cells specific for: 
Responder  FLD  FTD  Third party 
1310.2"  1:593  1:84  1:36 
1310.5"  <1:2,400  1:171  1:80 
IM93"  1:1,050  1:202  1:49 
CBlt  ND  ND  1:50 
" All SCID-hu mice were constructed with fetal liver and thymus from 
different donors.  1310.2 and 1310.5 animals were constructed with material 
from FLD K395 and FTD SV031; IM93 was constructed with material 
from FLD  Fl115  and FTD  Fl116. 
t CB1,  cord blood CDS*  cells were used as control. 
ance, as defined by the absence of GVHD or skin graft rejec- 
tion, is invariably achieved in radiation bone marrow chimeras 
(7, 10, 11), thymus-grafted chimeras (17, 19), and transgenic 
mice in which an MHC transgene is selectively expressed on 
thymic epithelial cells (37).  However, the in vitro prolifera- 
tive responses against the MHC antigens expressed in the 
thymus ranged from negative to normal (10,  11,  19). Gao 
et al. and Sprent et al. (10, 38) attributed the discrepancies 
among studies to the different sources of T  cells tested: in 
mice transplanted with denxygnanosine-treated  thymus as well 
as in bone marrow chimeras, nearly complete nonresponsive- 
ness was observed in the MLK when, as was the case in our 
study, thymocytes were used as responders, but only partial 
nonresponsiveness when lymph node T  cells were tested. 
Specific nonresponsiveness can be attributed to donal de- 
letion, donal anerg-y, or suppression. We excluded that the 
acquired nonresponsiveness to the HLA antigens of the FIT) 
observed in the SCID-hu mice was due to suppression since 
MLR, in which responder (FLDA/F'IT)^) and nonresponder 
(FLDs/FTDs) thymocytes were mixed, failed to show any 
inhibition even at the highest nonresponder to responder cell 
ratio. Limiting dilution analyses were performed to define 
whether clonal deletion of FTD-specific T  cells might ac- 
count for this nonresponsiveness. In these assays, T cells were 
activated with mitogens in the presence of I1:2 and in the 
absence of the tolerogen to revert possible  anergy of FTD- 
specific T  cells.  Similar assays were successfully used in a 
previous study to exclude clonal deletion of donor-specific 
T cells as the cause of the acquired peripheral tolerance ob- 
served, both in vitro and in vitro, in a patient with a suc- 
cessful kidney graft (29).  In addition, it has been reported 
in experimental in vivo models that anergy can be reversed 
when the tolerogen is removed (39, 40). Furthermore, in vitro 
studies have shown that cells, which do not respond to an- 
tigen or TCR-specific mAbs, may proliferate when stimu- 
lated with mitogens (41, 42) or when activated in the pres- 
ence of Ib2  (43, 44). 
In the SCID-hu mice studied here, FTD-specific CD4 + 
as  well  as  CD8 §  T  cells  were detected despite the non- 
responsiveness of these cells in the MLR. No autologous FLD- 
specific CD8*  T ceils could be detected, and minimal reac- 
tivity of FLD specific CD4 + T  cells was measured. These 
results indicate that T cells reacting with the HLA antigens 
expressed by the FLD are clonally ddeted, whereas FTD- 
specific T  cells are not. However, the frequencies of FTD- 
specific T cells were about twofold lower than those of third- 
party-reactive T  cells. Furthermore, the mean cytotoxic ac- 
tivity of FTD-specific CD8 § T cells was significantly lower 
compared with that of T ceils specific for third-party HLA 
antigens.  A  similar  tendency,  although  not  statistically 
significant,  was  observed  for  II.,2  production  by  CD4 + 
population. In addition, preliminary experiments in which 
lymphokine production by 10 FTD-specific T cell clones and 
10  third-party-reactive  clones  was  compared,  showed 
significantly lower production of Ib2 by Ag-stimulated FTD- 
specific clones (0.49 ng IL-2/ml vs.  1.98 ng IL-2/ml; Wil- 
coxon, p  <0.05).  Collectively, these data indicate that the 
1040  Tolerance  Induction in SCID-hu Mice CD4 + and CD8 § T  cells with low and intermediate func- 
tional activity were still present whereas highly cytotoxic or 
high IL-2-producing T  cell clones specific for the HLA of 
the FTD were undetectable. This could be due to sdective 
clonal deletion of the FTD-specific T cell clones which have 
high atfinity for their antigen. Alternatively, is is possible 
that FTD-specific T cells are rendered anergic during matu- 
ration in the allogeneic thymus and that this anergy was only 
partially overcome in the limiting dilution assay. In support 
of the notion that FTD-specific T cells are anergic is the ob- 
servation that the MLR to FTD HLA antigens was com- 
pletely negative. 
The data obtained so far are comparable with those previ- 
ously described in SCID children transplanted with fetal al- 
logeneic stem cells. Host-reactive T cells but not donor-reactive 
T  cells are detectable in the blood of these patients despite 
the nonresponsiveness of these T cells towards both the FLD 
and the host (21-23).  By taking advantage of the SCID-hu 
model, we are now able to correlate these functional data 
with the histologic composition of the chimeric thymus. 
Hematopoietic cei/s, in particular the cells expressing HLA 
class II antigens, are potent inducers of clonal deletion in ex- 
perimental animals (12). DC and CD5 § B ceils, but not M~ 
(13-15),  were shown to be the most effective in this respect. 
In contrast, no or only partial tonal deletion is induced by 
thymic epithelium (11). In a mouse transgenic model with 
selective expression of H-2 I-E on thymic epithelium cells, 
,,020%  reduction of I-E-reactive T  cells was observed (7). 
In the SCID-hu mice, thymic cortical and medullary epithe- 
lium originated from the FTD. HLA class II-expressing cells 
of FLD origin were abundantly present in the medulla and 
corticomedunary area and consisted mainly of CD11c § cells 
and CD1 + DC  (32,  33).  No CD1 + DC  of FTD  origin 
were detected in the medulla, indicating that by 7 mo after 
transplantation endogenous DC are replaced by FLD-derived 
calls. Virtually all the cells expressing CDllc were of FLD 
origin. In one SCID-hu mouse, however, a few monocyte- 
like ceils of FTD origin, expressing high levels of HLA class 
II, were detectable 7 mo after transplantation. The turnover 
rates for DC and Mr  previously reported in human and in 
animal models are compatible with this observation (45). In 
a rat model, it was demonstrated that DC are completely 
replaced within 3 wk, whereas Mr turnover requires months, 
and some endogenous Mr can still be found 1 yr after trans- 
plantation  (45).  CD19 *  B  cells  were  detectable  in  the 
thymus of SCID-hu mice by FACS  |  analysis but not by im- 
munohistology. These cells are CD5  dull and are of FLD 
origin by 6 mo after transplantation (Vandekerckhove et al., 
manuscript in preparation). 
In  summary, we have  demonstrated that  the SCID-hu 
thymus is composed of human pre-T cells, T  ceils, B cells, 
DC, and MS of FLD origin, whereas the thymic epithelium 
cells and possibly a few resident M$ are derived from the 
FTD. In these mice, human T cells educated in an allogenic 
host thymus, are rendered tolerant to autologous FLD as well 
as host FTD HLA antigens. Tolerance to the FLD is achieved 
by clonal deletion of FLD-reactive ceils,  whereas tolerance 
towards the FTD is mediated by tonal anergy and possibly 
clonal deletion of clones with high affinity for FTD HLA 
antigens. These data are comparable with those obtained in 
murine transplantation models (1-19). We therefore propose 
a similar sequence of events leading to serf-tolerance in the 
human thymus: during passage through the thymus, FLD- 
specific cells are negatively selected upon interaction with FLD- 
derived DC, B cells, or M~. FTD-specitic T cells with high 
affinity may be deleted by FTD-derived thymic epithdial cells. 
The role in the induction of  tonal deletion of  few M~ present 
in the thymus of some SCID-hu mice is probably minor since 
results obtained in these animals and in those where no M~ 
could be detected were comparable. The FTD-specific dories 
that escape clonal deletion by thymic epithelial cells are ren- 
dered anergic upon interaction with these cells. 
These findings have important clinical implications for al- 
logeneic stem cell transplantations.  They predict that allogeneic 
HLA-mismatched transplantation of stem cells can lead to 
a complete reconstitution of the T cell compartment, which 
will be tolerant to itsdf as well as to the host, even in situa- 
tions where the recipient hematopoietic cells are absent due 
to the preconditioning regimen. Some degree of HLA sharing 
between peripheral APC and thymic epithelium is needed 
only to ensure antigen-spedfic MHC-restricted T  cell re- 
sponses. However, since the tolerance for host antigens is not 
caused by complete elimination of host-reactive cells, it is pos- 
sible  that these T  cells can become functional. In patients 
who received an allogeneic bone marrow transplantation as 
part of the treatment for leukemia, it might be advantageous 
to manipulate these host-reactive cells to initiate a graft-vs.- 
leukemia effect (46). 
We are grateful to Drs. J. Mike McCune (SyStemix Inc.), Hergen Spits, and Jan E. de Vries for scientific 
discussions. We thank Dr. John Krowka (SyStemix Inc.) for providing some of the SCID-hu mice; Mr. 
Stacy Fucino and Mrs. Debbie Jones for transplanting SCID mice; Drs. H. Bruning, F. Koning (Immuno- 
haematology, Leiden, The Netherlands), and J. Phillips for providing mAbs; Mrs. Jean Hermann, Mrs. 
Dixie Polakoff, and Dr. Jim Cupp for cell sorting; and finally, Mrs. Janet Dillon for typing the manuscript. 
The DNAX Research Institute of Molecular and Cellular Biology is supported by Schering-Plough Cor- 
poration. 
1041  Vandekerckhove  et al. Address correspondence to Maria-Grazia Roncarolo, Human Immunology Department, DNAX Research 
Institute, 901 California Avenue,  Palo Alto, CA 94304. 
Received for publication 27 December  1991. 
~rellces 
1.  M6ller,  G.  1991. Transgenic  mice and immunological toler- 
ance. Iramunol. Peg. 122:1. 
2.  Herman, A., J.W. Kappler, P. Marrack, and A.M. Pullen. 1991. 
Superantigens:  mechanism of T-cell stimulation and role in im- 
mune responses.  Annu. Ret,. lmmunol. 9:745. 
3.  Kappler, J.W., N. Roehm, and P. Marrack. 1987. T cell toler- 
ance by clonal elimination in the thymus. Cell. 49:273. 
4.  Kappler, J.W., U. Staerz, J. White, and PC. Marrack.  1988. 
Self-tolerance eliminates T cells specific for Mls-modified prod- 
ucts of the major histocompatibility complex. Nature (Lond.). 
332:35. 
5.  MacDonald, H.R., R. Schneider, R.K. Lees, R.C. Howe, H. 
Acha-Orbea, H. Festenstein,  R.M. Zinkernagel, and H. Hen- 
garmer.  1988. T-cell receptor Va use predicts reactivity and 
tolerance to M/s~-encoded  antigens. Nature (Lond.). 332:40. 
6.  Kisielow, P., H. BlQthmann, U.D. Staerz, M. Steinmetz, and 
H. yon Boehmer. 1988. Tolerance in T-cell-receptor transgenic 
mice involves deletion of nonmature CD4*8"  thymocytes. 
Nature (Land.). 333:742. 
7.  Marrack, P., D. Lo, R. Brinster, R. Palmiter, L. Burkly, R.H. 
Flavell, and J. Kappler.  1988. The effect of thymus environ- 
ment on T  cell development and tolerance.  Cell. 53:627. 
8.  Ramsdell, F., T. Lantz, and B.J. Fowlkes.  1989.  A nondele- 
tional mechanism of thymic self tolerance. Science  (Wash. DC). 
246:1038. 
9.  Blackman, M.A.,  H. Gerhard-Burgert, D.L. Woodland,  E. 
Palmer, J.W. Kappler, and P. Marrack. 1990. A role for clonal 
inactivation  in  T  cell  tolerance  to  MIs-P.  Nature (Land.). 
345:540. 
10.  Gao, E.-K., D. LO, andJ. Sprent. 1990. Strong T cell tolerance 
in  parent  --*  F1  bone  marrow  chimeras  prepared  with 
supralethal irradiation:  evidence for clonal deletion and anergy. 
J. Exit Med. 171:1101. 
11.  Ramsdell, F., and B.J. Fowlkes.  1990. Clonal deletion versus 
clonal anergy: the role of the thymus in inducing self toler- 
ance. Science (Wash. DC).  248:1342. 
12.  Sprent, J., H. Von Boehmer, and M. Nabholz. 1975. Associa- 
tion of immunity and tolerance to host H-2 determinants in 
irradiated  F1 hybrid mice reconstituted with bone marrow 
cells form one parental strain. J. Exit Med. 142:321. 
13.  Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance re- 
quire a dedicated antigen-presenting  cell? Nature(Latul.). 338:74. 
14.  Mazda, O., Y. Watanabe, J.-l. Gyotoku, and Y. Katsura.  1991. 
Requirement of dendritic cells and B cells in the clonal dele- 
tion of Mls-reactive T cells in the thymus.J. Exit Med. 173:539. 
!5.  Inaba,  M., K. Inaba, M. Hosono, T. Kumamoto, T. Ishida, 
S. Muramat.su, T. Masuda, and S. Ikehara. 1991. Distinct mech- 
anisms  of neonatal tolerance induced by dendritic cells and 
thymic B cells, f  Exit Med. 173:549. 
16.  Speiser, D.E., R.K. Lees, H. Hengartner, R.M. Zinkernagel, 
and H.R. MacDonald.  1989. Positive and negative selection 
of T cell receptor VB domains controlled by distinct cell popu- 
lations in the thymus, f  Exit IVied. 170:2165. 
17.  Ready, A.R., E.J. Jenkinson, R. Kingston, and J.J.T. Owen. 
1984. Successful transplantation  across major histocompatibility 
barrier of deoxyguanosine-treated embryonic thymus expressing 
class II antigens. Nature (Lond.). 310:231. 
18.  Von Boehmer, H., and K. Schubiger.  1984. Thymocytes ap- 
pear to ignore class I major histocompatibility complex an- 
tigens expressed  on thymus epithelial  cells. Eur. J. Immunol. 
14:1048. 
19.  Salaun, J., A. Bandeira,  I.  Khazaal,  F. Caiman,  M. Coltey, 
A. Coutinho, and N.M.  Le Douatin.  1990. Thymic epithe- 
lium toletizes for histocompatibility antigens. Science (Wash. 
DC).  247:1471. 
20.  Touraine, J.-L., M.-G. Roncarolo, C. Royo, and F. Touraine. 
1987. Fetal tissue  transplantation, bone marrow transplanta- 
tion and prospective gene therapy in severe immunodeficiencies 
and enzyme deficiencies.  Thymus. 10:75.. 
21.  Spits, H., J.-L. Touraine,  H. Yssel, J.E. de Vries, and M.-G. 
Roncarolo.  1990. Presence of host-reactive and MHC-restticted 
T  cells in  a transplanted severe combined immunodeficient 
(SCID) patient suggest positive selection and absence ofclonal 
deletion. Immunol. Rev. 116:101. 
22.  goncarolo, M.-G., H. Yssel, J.-L. Touraine,  H. Betuel, J.E. 
de Vties, and H. Spits. 1988. Auto-reactive T cell clones specific 
for class I and class II HLA antigens isolated  from a human 
chimera. J. Exit Med. 167:1523. 
23.  Roncarolo, M.-G., H. Yssel, J.-L. Touraine, R. Bacchetta, L. 
Gebuhrer, J.E. de "Cries, and H. Spits. 1988. Antigen recogni- 
tion by MHC-incompatible cells of a human mismatched chi- 
mera. J. Exit Med. 168:2139. 
24.  goncarolo, M.-G., J.L.  Touraine,  and J.  Banchereau.  1986. 
Cooperation between major histocompatibility complex mis- 
matched  mononuclear cells  from  a  human  chimera in  the 
production of antigen-specific antibody.J. Clin. Invest. 77:673. 
25.  McCune, J.M., R. Namikawa, H. Kaneshima, L.D. Schultz, 
M. Lieberman, and I.L. Weissman. 1988. The SCID-hu mouse: 
murine model for the analysis  of human  hematolymphoid 
differentiation and function. Science (Wash. DC). 241:1632. 
26.  Namikawa, R., K.N. Weilbaecher,  H. Kaneshima,  E.J.  Yee, 
and J.M. McCune. 1990. Long-term human hematopoiesis in 
the SCID-hu mouse, f  Exit Med. 72:1055. 
27.  Krowka, J.F., S. Satin, g. Namikawa, J.M. McCune, and H. 
Kaneshima.  1991. Human T cells in the SCID-hu mouse are 
phenotypically normal and functionally competent.f lmmunol. 
146:3751. 
28.  Vandekerckhove, B.A.E., J.F. Krowka, M.J. McCune, J.E. de 
'Cries, H. Spits, and M.-G.  Koncarolo. 1991. Clonal analysis 
of the peripheral T cell compartment of the SCID-hu mouse. 
f  Immunol. 146:4173. 
29.  Vandekerckhove, B.A.E., G. Datema, F. Koning, E. Goulmy, 
G.G. Persijn, J.J. Van Rood, F.H.J. Clans, and J.E. de Vties. 
1990. Analysis of the donor-specific  cytotoxic T lymphocyte 
repertoire in a patient with a long term surviving allograft: 
frequency, specificity, and phenotype of donor-reactive T cell 
receptor (TCR)-c~fl*  and TCR3,~" clones, f  Imraunol. 144: 
1288. 
1042  Tolerance  Induction in SCID-hu Mice 30.  Gillis,  S., W.  Ferm, W. Ou, and K.A. Smith.  1978.  T  cell 
growth factor: parameters of production and a quantitative 
micro assay for activity. J. Immunol. 120:2027. 
31.  Paliard, X., K. de Waal Malefyt, H. Yssel, D. Blanchard, I. 
Chr&ien, J. Abrams, J.E. de Vries, and H. Spits. 1988. Simul- 
taneous production of IL-2, IL-4, and IFN-3' by activated human 
CD4 § and CD8 § T  cell clones, f. Immunol. 141:849. 
32.  Landry,  D., M. Lafontaine,  M. Cossette, H. Barthr162  C. 
Chartrand,  S.  Montplaisir,  and  M.  Pelletier.  1988.  Human 
thymic dendritic cells. Characterization, isolation, and func- 
tional assays. Immunology. 65:135. 
33.  Haynes, B.F. 1990. Human thymic epithelium and T cell de- 
velopment: current issues and future directions. Th~u~ 16:143. 
34.  Hogg, N., L. Takacs, D.G. Palmer, Y. Salverdran, and C. Allen. 
1986. The p150,95 is a marker of human phagocytes: compar- 
ison with expression  of class II molecules.  Eur. f. Immunol. 
16:240. 
35.  Freundenthal, P.S., and R.M.  Steinman.  1990. The distinct 
surface of human blood dendritic cells, as observed after an 
improved isolation method. Proc. Natl. Acad. Sci. USA. 87:7698. 
36.  Pilarski, L.M. 1977. A requirement for antigen-specific  helper 
T cells in the generation of cytotoxic T cells from thymocyte 
precursors, f  Exp. Med. 145:709. 
37.  van Ewijk, W., Y. Ron, J. Monaco, J. Kappler,  P. Marrack, 
M.  Le Meur,  P. Gerlinger, B. Durand,  C.  Benoist, and D. 
Mathis.  1988. Compartmentalization of MHC class II gene 
expression in transgenic mice.  Cell. 53:357. 
38.  Sprent, J., E.-K. Gao, and S.R. Webb.  1990. T cell reactivity 
to MHC molecules: immunity versus tolerance. Science (Wash. 
DC).  248:1357. 
39.  Olausson, M., L. Mjornstedt, L. Wramner, T. Soderstrom, 
and H. Brynger. 1987. Importance of the presence of antigen 
for induction  of transplantation  tolerance.  Transplant. Proc. 
19:454. 
40.  Sch6nrich, G., U. Kalinke, F. Momburg, M. Malissen, A.-M. 
Schmitt-Verhulst,  B. Malissen,  G.J. Himmerling, and B. Ar- 
nold. 1991. Down-regulation of T cell receptors on self-reactive 
T cells as a novel mechanism for extrathymic tolerance induc- 
tion. Cell. 65:293. 
41.  Finkel,  T.H., J.C. Cambier, R.T. Kubo, W.K. Born, P. Mar- 
rack, and J.W. Kappler.  1989. The thymus has two function- 
ally distinct populations of immature otl$  § T cells: one popu- 
lation is deleted by ligation of ~BTCR.  Cell. 58:1047. 
42.  Blackman, M., J. Kappler, and P. Marrack. 1990. The role of 
the T  cell receptor in positive  and negative selection  of de- 
veloping T  cells. Science (Wash. DC). 248:1335. 
43.  Essery, G., M. Feldmann, andJ.R. Lamb. 1988. Interleukin-2 
can prevent and reverse antigen-induced unresponsiveness  in 
cloned human T  lymphocytes. Immunology. 64:413. 
44.  Schwartz, R.H. 1990. A cell culture model for T lymphocyte 
clonal anergy.  Science (Wash. DC).  248:1349. 
45.  Kampinga, J., P. Nieuwenhuis,  B. Roser, and R. Aspinan. 1990. 
Differences  in turnover between thymic medullary dendritic 
cells and a subset of cortical macrophages.J.  Immunol. 145:1659. 
46.  Falkenburg, J.H.F., H.M. Goselink, D. Van der Harst, S.A.P. 
Van Luxemburg-Heijs, E.M.C. Kooij-Winkelaar,  L.M. Faber, 
J.  De Kroon, A.  Brand, W.E.  Fibbe,  R.  Willemze, and E. 
Goulmy.  1991. Growth  inhibition  of clonogenic leukemic 
precursor cells by minor histocompatibility antigen specific  cyto- 
toxic T  lymphocytes, j. Ex  F Med. 174:27. 
1043  Vandekerckhove  et al. 